GO
Loading...

Celgene Corp

More

  • Slight gains for stocks in quiet post-holiday day Friday, 26 Dec 2014 | 4:11 PM ET

    U.S. stocks are posting modest gains after a quiet, post-holiday day of trading. Celgene rose 3.4 percent, the most in the S&P 500 index. Benchmark U.S. crude oil fell $1.11 to close at $54.73 a barrel in New York.

  • Midday Glance: Biotechnology companies Friday, 26 Dec 2014 | 1:20 PM ET

    Amgen Inc. rose $2.54 or 1.6 percent, to $163.21. Biogen Idec rose$. 53 or. 2 percent, to $341.41. Celgene Corp. rose $3.29 or 3.0 percent, to $112.89.

  • NEW YORK, Dec 26- U.S. stocks rose on Friday, with major indexes hitting records and on track for a second straight weekly advance, though trading was light with many traders still out for the Christmas holiday. The advance continued Wall Street's recent upward bias, with the S&P up about 6 percent from a recent closing low hit earlier this month.

  • Early Glance: Biotechnology companies Friday, 26 Dec 2014 | 10:23 AM ET

    Amgen Inc. rose $2.52 or 1.6 percent, to $163.19. Biogen Idec rose $1.65 or. 5 percent, to $342.54. Celgene Corp. rose $3.15 or 2.9 percent, to $112.75.

  • NEW YORK, Dec 26- U.S. stocks rose on Friday, with major indexes hitting new records and on track for a second straight weekly advance, though trading was light with many traders still out for the Christmas holiday. The advance continued Wall Street's recent upward bias, with the S&P up about 6 percent from a recent closing low hit earlier this month.

  • US stocks close higher, extending gains for the week Friday, 26 Dec 2014 | 12:40 AM ET

    Wall Street's "Santa Claus" rally kept delivering gifts a day after Christmas. The Dow Jones industrial average, Standard& Poor's 500 index and the Russell 2000 index of small-company stocks closed at all-time highs on Friday. The consumer is in good shape, "said David Chalupnik, head of equities at Nuveen Asset Management.

  • *Initial jobless claims fall for fourth straight week. *Biotech shares rebound after sharp two-day decline; energy falls. NEW YORK, Dec 24- U.S. stocks closed flat in a short session on Wednesday as investors found few reasons to push major indexes to their sixth straight day of gains despite strength in biotechs and bullish labor market data.

  • *Initial jobless claims fall for fourth straight week. *Equity markets close at 1 p.m. in holiday-shortened session. NEW YORK, Dec 24- U.S. stocks edged higher on Wednesday, with the Dow and S&P 500 at records and on track for a sixth straight daily advance as biotech stocks rallied and data pointed to improving economic conditions.

  • Early Glance: Biotechnology companies Wednesday, 24 Dec 2014 | 10:23 AM ET

    Amgen Inc. rose $4.40 or 2.8 percent, to $161.92. Biogen Idec rose $4.11 or 1.2 percent, to $339.87. Celgene Corp. rose $3.71 or 3.5 percent, to $109.83.

  • Final Glance: Biotechnology companies Tuesday, 23 Dec 2014 | 6:06 PM ET

    Amgen Inc. fell $7.01 or 4.3 percent, to $157.52. Biogen Idec fell $16.53 or 4.7 percent, to $335.76. Celgene Corp. fell $7.38 or 6.5 percent, to $106.12.

  • Hertz and Green Mountain are big market movers Tuesday, 23 Dec 2014 | 4:52 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:. Chesapeake Energy Corp., up $1.87 to $20.29. The energy company completed a $5 billion asset sale around Pennsylvania and West Virginia and announced a $1 billion share buyback.

  • *Dow, S&P rise for 5th day, both end at records. NEW YORK, Dec 23- U.S. stocks rose on Tuesday, with the Dow closing above 18,000 for the first time ever and the S&P 500 ending at a record after an unexpectedly strong report on economic growth. The Dow rose as high as 18,069.22 and is up about 175 percent from a 12- year closing low hit on March 9, 2009.

  • Most active Nasdaq-traded stocks Tuesday, 23 Dec 2014 | 1:22 PM ET

    Achillion Pharmaceuticals Inc. fell 23.6 percent to $11.84 with 28,871,400 shares traded. Apple Inc. fell. 4 percent to $112.54 with 24,723,500 shares traded. Celgene Corp. fell 6.5 percent to $106.12 with 17,637,300 shares traded.

  • Midday Glance: Biotechnology companies Tuesday, 23 Dec 2014 | 1:22 PM ET

    Amgen Inc. fell $9.68 or 5.9 percent, to $154.85. Biogen Idec fell $23.27 or 6.6 percent, to $329.02. Celgene Corp. fell $9.05 or 8.0 percent, to $104.46.

  • NEW YORK, Dec 23- U.S. stocks rose for a fifth straight session on Tuesday, with the Dow climbing above 18,000 for the first time ever after an unexpectedly strong report on economic growth. Both the Dow and S&P 500 hit intraday records, and the S&P is on track for its 51st record close of 2014. The gains pushed the Dow as high as 18,051.14, and the blue-chip index is now up...

  • LOS ANGELES, Dec 23- Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year. On Monday, Express Scripts said it lined up a cheaper price for AbbVie Inc's newly...

  • Final Glance: Biotechnology companies Monday, 22 Dec 2014 | 7:19 PM ET

    Amgen Inc. fell $5.64 or 3.3 percent, to $164.53. Biogen Idec fell $8.38 or 2.3 percent, to $352.29. Celgene Corp. fell $3.68 or 3.1 percent, to $113.50.

  • Dec 22- The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's treatments after trying for nearly a year to win a deeper discount. Express Scripts' move reignited investor concerns that pharmaceutical companies...

  • Midday Glance: Biotechnology companies Monday, 22 Dec 2014 | 1:22 PM ET

    Amgen Inc. fell $3.99 or 2.3 percent, to $166.18. Biogen Idec fell $4.67 or 1.3 percent, to $356.00. Celgene Corp. fell $2.48 or 2.1 percent, to $114.70.

  • Early Glance: Biotechnology companies Monday, 22 Dec 2014 | 10:22 AM ET

    Amgen Inc. fell $3.09 or 1.8 percent, to $167.08. Biogen Idec fell $8.52 or 2.4 percent, to $352.15. Celgene Corp. fell $2.48 or 2.1 percent, to $114.70.